SanBio Company LimitedJP:4592
| Jan 31,
2014 | Jan 31,
2015 | Jan 31,
2016 | Jan 31,
2017 | Jan 31,
2018 | Jan 31,
2019 | Jan 31,
2020 | Jan 31,
2021 | Jan 31,
2022 | Jan 31,
2023 | Jan 31,
2024 |
|---|
| Profit (loss) before income taxes | -589 | 2,228 | -1,172 | -2,166 | -3,939 | -2,919 | -5,157 | -3,211 | -4,560 | -4,697 | -2,542 |
|---|
| Depreciation | 4 | 6 | 14 | 27 | 54 | 37 | 40 | 74 | 132 | 25 | 15 |
|---|
| Share-based payment expenses | - | - | - | 15 | 13 | 28 | 71 | 112 | 141 | 103 | 34 |
|---|
| Increase (decrease) in provision for bonuses | - | 10 | 11 | -6 | -13 | - | 21 | -14 | 15 | 38 | -57 |
|---|
| Interest and dividend income | - | - | - | - | - | -13 | -16 | -9 | -5 | -4 | -2 |
|---|
| Foreign exchange losses (gains) | - | 5 | -37 | 366 | 48 | -21 | -7 | 634 | -1,964 | -3,381 | -1,652 |
|---|
| Interest expenses | - | 5 | 18 | 13 | 26 | 34 | 47 | 47 | 45 | 25 | 11 |
|---|
| Financing expenses | - | - | - | 31 | 67 | 59 | 9 | 56 | 10 | 31 | 15 |
|---|
| Share issuance costs | - | - | 32 | - | - | 57 | 50 | - | - | 72 | 9 |
|---|
| Gain on reversal of share acquisition rights | - | - | - | - | -9 | -1 | - | - | -29 | - | -252 |
|---|
| Loss (gain) on sale of non-current assets | - | - | - | - | - | - | - | - | - | -1 | -34 |
|---|
| Loss on retirement of non-current assets | 1 | 0 | 0 | - | - | - | 10 | 0 | 10 | 0 | 3 |
|---|
| Decrease (increase) in supplies | - | - | - | - | - | - | -470 | 14 | 3 | 510 | - |
|---|
| Decrease (increase) in advance payments to suppliers | -6 | 1 | -432 | -74 | 104 | -147 | 144 | 257 | -61 | 163 | -295 |
|---|
| Increase (decrease) in accounts payable - other | -51 | -28 | 235 | -106 | 403 | -211 | -22 | -66 | 101 | -52 | -231 |
|---|
| Increase (decrease) in accrued expenses | 43 | -14 | -46 | 178 | 4 | -47 | 163 | 254 | -22 | -189 | 138 |
|---|
| Other, net | - | - | - | 1 | 8 | -1 | 1 | 11 | -6 | 36 | 83 |
|---|
| Subtotal | -112 | -212 | -1,345 | -1,792 | -3,910 | -4,064 | -5,684 | -5,160 | -6,319 | -7,323 | -4,757 |
|---|
| Interest and dividends received | - | - | - | - | - | 16 | 16 | 9 | 5 | 4 | 2 |
|---|
| Interest paid | - | -7 | -18 | -10 | -25 | -33 | -48 | -49 | -46 | -26 | -11 |
|---|
| Income taxes paid | - | -0 | -0 | -2 | -3 | -0 | -1 | -16 | -188 | -89 | -1 |
|---|
| Net cash provided by (used in) operating activities | -112 | -219 | -1,362 | -1,796 | -1,907 | -3,968 | -5,717 | -5,216 | -6,547 | -7,434 | -4,766 |
|---|
| Purchase of property, plant and equipment | -10 | -3 | -60 | -97 | -32 | -6 | -96 | -96 | -42 | -8 | -11 |
|---|
| Proceeds from sale of property, plant and equipment | - | - | - | 3 | - | - | - | - | - | 1 | 36 |
|---|
| Purchase of intangible assets | - | - | - | - | - | - | -11 | -43 | -14 | -0 | -44 |
|---|
| Payments of leasehold deposits | - | - | - | - | - | -1 | -8 | -0 | -18 | -4 | - |
|---|
| Net cash provided by (used in) investing activities | 523 | -480 | -436 | 79 | 658 | -1,007 | -115 | 4,180 | -66 | -10 | -19 |
|---|
| Repayments of long-term borrowings | - | - | - | -800 | -550 | -67 | -533 | -2,800 | -975 | -1,592 | -268 |
|---|
| Payments of financing expenses | - | - | - | -30 | -64 | -59 | -12 | -57 | -24 | -18 | -13 |
|---|
| Proceeds from issuance of shares resulting from exercise of share acquisition rights | - | 23 | 75 | 90 | 46 | 10,946 | 20 | 0 | 4 | 10,957 | 2,651 |
|---|
| Proceeds from issuance of share acquisition rights | - | - | - | - | - | 100 | - | - | - | 99 | - |
|---|
| Other, net | - | 1 | -0 | -0 | -0 | -1 | -0 | - | - | -0 | -0 |
|---|
| Net cash provided by (used in) financing activities | 0 | 1,374 | 7,402 | 159 | 982 | 12,720 | 7,022 | -57 | -1,495 | 9,446 | 2,371 |
|---|
| Effect of exchange rate change on cash and cash equivalents | -10 | 115 | 55 | -454 | 44 | 54 | 3 | -74 | 185 | 117 | 128 |
|---|
| Net increase (decrease) in cash and cash equivalents | 402 | 790 | 5,659 | -2,011 | -222 | 7,798 | 1,193 | -1,166 | -7,923 | 2,118 | -2,286 |
|---|